Vol 8, No 3 (2024) Uro-Technology Journal

Table of Contents

Editorial

The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?
Francesco Greco, Luigi Domanico
Received: Tuesday, July 23, 2024      Published: Tuesday, September 24, 2024 Pages: 30-32
PDF

Original Article

The effects of 5-ARIs on prostate volume in patients with or without heart failure and benign prostate hyperplasia: prospective, comparative study
Denis V Krakhotkin, Volodymyr A. Chernylovskyi, Francesco Greco, Aly M Abdel-Karim, Ali Serdar Gözen, Anastasia G. Korplyakova, Nikolay Yu. Iglovikov
Received: Monday, June 17, 2024      Published: Tuesday, September 24, 2024 Pages: 33-40
PDF

Case Report

Robot-assisted pyeloplasty and pyelolithotomy in patient with osteogenesis imperfecta
Video
Marco Rinaldi, Carmine Franzese, Jeanlou Collavino, Maria Abbinante, Sasha Sekulovic, Gioacchino De Giorgi, Fabio Traunero, Gianluca Giannarini, Alessandro Crestani
Received: Monday, June 3, 2024      Published: Tuesday, September 24, 2024 Pages: 41-43
PDF

Brief Correspondence

Neoadjuvant chemotherapy should only be considered in patients with cT3-T4a muscle-invasive bladder cancer
Sytse C. van Beek, Noor van Ginkel, Joost L. Boormans, André N. Vis, Dutch Cystectomy Snapshot Research Group
Received: Tuesday, July 30, 2024      Published: Tuesday, September 24, 2024 Pages: 44-46
PDF

Interview

Minimally invasive surgical therapies (MISTs) for benign prostatic hyperplasia: current insights and future directions—Interview with Prof. Francesco Greco
Carlotta Nedbal
Received: Wednesday, August 7, 2024      Published: Tuesday, September 24, 2024 Pages: 47-49
PDF HTML


FRIENDLINKS

THE ANT JOURNALS

Subscribe to receive issue release notifications
and newsletters from journals

Select Joumal/Joumals:

Copyright © 2017 - 2024 Ant Publishing Corporation. All rights reserved.